Medical Research
(H12)
IRS Verified
DX Registered
990 on File
COMING TOGETHER FOR A CURE INC
Financial strength (30%)
71/100
Reliability (20%)
45/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
To build awareness for adult stem cell research and therapy through various community events while partnering with organizations with similar aspirations to help advance the medical research and bring more people the opportunity for treatment.
Financial Overview — FY 2024
$4.0M
Total Revenue
$4.0M
Total Expenses
$51K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
93.9%
Fundraising Efficiency
0.0%
Operating Reserve
0.15x
Liability-to-Asset
0.0%
Revenue Diversification
99.9%
Executive Compensation
$129K
Compared with Peers
FY 2024
Compared with 332 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
93.9% | 83.0% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
6.1% | 10.7% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 2.0% |
P10P90
|
Top quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
0.0% | 97.3% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
0.2 mo | 12.8 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 10.1% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.9% | 90.7% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
109.4% | 12.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
113.4% | 11.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-0.8% | 2.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $4.0M | $4.0M | $51K | 93.9% | 0 |
| 2023 | $1.9M | $1.9M | $83K | 90.4% | 0 |
| 2022 | $70K | $107K | $62K | 0.0% | — |
| 2021 | $133K | $54K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.